GSK1349572 Drug Interaction Study With Efavirenz

Clinical trial NCT01098526 · COMPLETED

Trial details

NCT number: NCT01098526
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Human Immunodeficiency Virus and Herpesviridae

Start date: 2010-03-16
Primary completion: 2010-05-26
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.